Literature DB >> 32524906

The effect of desloratadine on ischemia reperfusion induced oxidative and inflammatory renal injury in rats.

Huseyin Kocaturk1, Fevzi Bedir1, Mehmet Sefa Altay1, Ebubekir Bakan2, Bahadir Suleyman3, Gulce Naz Yazici4, Mukadder Sunar5, Zeynep Suleyman6, Halis Suleyman3.   

Abstract

Purpose: To examine the effect of desloratadine on kidney ischemia-reperfusion (I/R) injury in albino Wistar male rats using biochemical and histopathological methods.
Methods: The treated with ischemia-reperfusion + 5 mg/kg desloratadine (IRD) group (n-6) was given 5 mg/kg desloratadine by gavage orally, and applied renal ischemia-reperfusion (BIR) group (n-6) and control (SG) group undergoing Sham operation (n-6) rats were given distilled water as solvent one hour before ketamine anesthesia. During the anesthesia period, ischemia was induced for 2 h unilaterally in the left kidney of all rats followed by reperfusion for 6 h. The kidneys of the SG group had sham operation without any intervention.
Results: Our biochemical test results showed that malondialdehyde (MDA), nuclear factor kappa (NF-κB), tumor necrosis factor alpha (TNF-α), interleukin one beta (IL-1β), creatinine, and blood urea nitrogen (BUN) levels were significantly increased in the BIR group compared to the healthy control and IRD groups treated with desloratadine. Histopathological results were revealed tubular dilatation, tubular necrosis, loss of brushy margins, cast formation, and apoptotic bodies in tubular epithelial cells in the BIR group. There were no histopathological findings except for the swelling of tubule epithelial cells and the accumulation of proteinous material in some tubule lumens in renal tissue of desloratadine-treated rats.Conclusions: Experimental results suggested that desloratadine may be useful in the treatment of renal I/R injury.

Entities:  

Keywords:  Desloratadine; ischemia; rat; renal; reperfusion

Year:  2020        PMID: 32524906      PMCID: PMC7946030          DOI: 10.1080/0886022X.2020.1769656

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  25 in total

1.  A smooth operator for LPS responses.

Authors:  Paul J Godowski
Journal:  Nat Immunol       Date:  2005-06       Impact factor: 25.606

2.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent.

Authors:  J Sedlak; R H Lindsay
Journal:  Anal Biochem       Date:  1968-10-24       Impact factor: 3.365

3.  The ameliorative effect of berberine and coenzyme Q10 in an ovalbumin-induced allergic rhinitis model.

Authors:  Muhammed Sedat Sakat; Korhan Kilic; Fatih Mehmet Kandemir; Serkan Yildirim; Abdulkadir Sahin; Sefa Kucukler; Yavuz Selim Saglam
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-23       Impact factor: 2.503

4.  Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.

Authors:  C Roumestan; C Henriquet; C Gougat; A Michel; F Bichon; K Portet; D Jaffuel; M Mathieu
Journal:  Clin Exp Allergy       Date:  2008-06       Impact factor: 5.018

5.  Protective effect of nimesulide against hepatic ischemia/reperfusion injury in rats: effects on oxidant/antioxidants, DNA mutation and COX-1/COX-2 levels.

Authors:  Ismail Demiryilmaz; Mehmet Ibrahim Turan; Abdullah Kisaoglu; Mine Gulapoglu; Ismayil Yilmaz; Halis Suleyman
Journal:  Pharmacol Rep       Date:  2014-03-11       Impact factor: 3.024

Review 6.  Acute renal failure.

Authors:  A Bidani; P C Churchill
Journal:  Dis Mon       Date:  1989-02       Impact factor: 3.800

7.  Contributions of ischemia and reperfusion to mucosal lesion formation.

Authors:  D A Parks; D N Granger
Journal:  Am J Physiol       Date:  1986-06

8.  Preventive effects of fraxin on ischemia/reperfusion-induced acute kidney injury in rats.

Authors:  Ömer Topdağı; Ayhan Tanyeli; Fazile Nur Ekinci Akdemir; Ersen Eraslan; Mustafa Can Güler; Selim Çomaklı
Journal:  Life Sci       Date:  2019-12-26       Impact factor: 5.037

9.  Ischemia-induced vascular changes: role of xanthine oxidase and hydroxyl radicals.

Authors:  D A Parks; D N Granger
Journal:  Am J Physiol       Date:  1983-08

10.  The Protective Role of Gallic Acid Pretreatment On Renal Ischemia-reperfusion Injury in Rats.

Authors:  Hassan Ahmadvand; Banafsheh Yalameha; Glavizh Adibhesami; Maryam Nasri; Negar Naderi; Esmaeel Babaeenezhad; Negar Nouryazdan
Journal:  Rep Biochem Mol Biol       Date:  2019-04
View more
  5 in total

1.  Rosmarinic Acid Ameliorates Pulmonary Ischemia/Reperfusion Injury by Activating the PI3K/Akt Signaling Pathway.

Authors:  Wenbin Luo; Yu Tao; Shengnan Chen; Hao Luo; Xiaoping Li; Shuang Qu; Ken Chen; Chunyu Zeng
Journal:  Front Pharmacol       Date:  2022-05-11       Impact factor: 5.988

2.  MicroRNA-490-3p inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats by suppressing the IRAK1/TRAF6 pathway.

Authors:  Guang Yang; Yuan Zhao
Journal:  Exp Ther Med       Date:  2020-12-17       Impact factor: 2.447

3.  microRNA-130a-5p suppresses myocardial ischemia reperfusion injury by downregulating the HMGB2/NF-κB axis.

Authors:  Yong Li; Hongbo Zhang; Zhanhu Li; Xiaoju Yan; Yuan Li; Shuai Liu
Journal:  BMC Cardiovasc Disord       Date:  2021-03-03       Impact factor: 2.298

Review 4.  The implications of histamine metabolism and signaling in renal function.

Authors:  Anastasia V Sudarikova; Mikhail V Fomin; Irina A Yankelevich; Daria V Ilatovskaya
Journal:  Physiol Rep       Date:  2021-04

5.  Combined Systemic Intake of K-ATP Opener (Nicorandil) and Mesenchymal Stem Cells Preconditioned With Nicorandil Alleviates Pancreatic Insufficiency in a Model of Bilateral Renal Ischemia/Reperfusion Injury.

Authors:  Asmaa Mohammed ShamsEldeen; Sarah A Abd El-Aal; Basma Emad Aboulhoda; Hend AbdAllah; Sara Mahmoud Gamal; Fatma E Hassan; Marwa Nagi Mehesen; Laila Ahmed Rashed; Abeer Mostafa; Nermeen Bakr Sadek
Journal:  Front Physiol       Date:  2022-06-23       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.